Evaluation of the Glucometer Elite XL device for screening for neonatal hypoglycaemia
| Autor: | Wilfried Paul, Ingrid Kadow, Andreas Michel, Christoph Fusch, Matthias Nauck, Alexander Krebs, H. Küster |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Blood Glucose
Pediatrics medicine.medical_specialty Point-of-Care Systems Point-of-care testing Hematocrit Hypoglycemia Sensitivity and Specificity Neonatal Screening Intensive care medicine Humans Blood Glucose Measurement Whole blood Glucometer elite medicine.diagnostic_test business.industry Glucose Measurement Infant Newborn Reproducibility of Results medicine.disease Equipment and Supplies Anesthesia Pediatrics Perinatology and Child Health Regression Analysis business Blood Chemical Analysis |
| Zdroj: | European Journal of Pediatrics. 164:660-664 |
| ISSN: | 1432-1076 0340-6199 |
| DOI: | 10.1007/s00431-005-1733-9 |
| Popis: | To prevent persistent neurodevelopment and physical growth deficits in neonatal care, it is mandatory to determine blood glucose levels as quickly and precisely as possible, preferably using micro-methods. However, most commercially available instruments have not been validated and approved for this purpose. The aim of this study was to validate the Glucometer Elite XL, a newly developed device for point-of-care testing (POCT). In samples from 869 newborn infants, glucose levels were simultaneously measured by the Glucometer Elite XL in whole blood and by an accepted clinical laboratory method in haemolysed blood using the ECA 2000 device. An acceptable method agreement was found between the POCT and the ECA 2000 method (mean difference 0.013 mmol/l, SD 0.69). As determined by regression analysis (Passing-Bablok), the slope was 1.086 with a y-intercept of −0.4 mmol/l ( r =0.959, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|